Absci Corporation stock has dropped since January, driven by weak earnings and broader biotech sector pressures. Learn more about ABSI stock here.

The deal is structured as a private investment in a public equity and includes an equity stake in Absci. AMD didn’t disclose the amount of its stake. AMD, which is based in Santa Clara ...

Absci gained on animal testing phaseout news, but the change has limited near-term impact on its investment case. Read why ...

Absci management will webcast a corresponding ... we are going to take a look at where Advanced Micro Devices, Inc. (NASDAQ:AMD) stands against other AI stocks. As per a CNBC report, in 2025 ...

Absci Corp's collaboration with AMD provides optimized compute solutions, enhancing performance and reducing costs for complex biological modeling. The company demonstrated significant ...

In a report released today, Scott Schoenhaus from KeyBanc maintained a Buy rating on AbSci (ABSI – Research Report), with a price target of $9.00. Discover outperforming stocks and invest ...

In January 2025, Absci entered a strategic collaboration with AMD (NASDAQ:AMD), including a $20 million equity investment from the chip maker. The partnership aims to leverage AMD’s AI ...

Ratings for Absci (NASDAQ:ABSI) were provided by 7 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The following table encapsulates their recent ratings ...

(MENAFN- GlobeNewsWire - Nasdaq) VANCOUVER, Wash. and NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today ...

16:31 EDT Absci (ABSI) files to sell 5.71M shares of common stock for holders Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks.